Kim Pharma Clenbuterol delivers 40 mcg of clenbuterol hydrochloride per tablet across a 100-tablet supply, formulated specifically for users who require tight cardiovascular load management during fat-loss protocols — addressing tachycardia risk, systolic blood pressure elevation, and cardiac output stress as primary safety considerations. Each tablet is individually dosed for precise incremental titration, enabling practitioners to stay within personally tolerable heart-rate thresholds rather than applying blanket dose schedules. Batch release is conditional on verified HPLC potency data and LAL endotoxin clearance; every pack leaving Kim Pharma's controlled-environment production line carries traceable documentation linking it to its specific production batch.
€30.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
Uniform 40 mcg per tablet enables one-increment cardiovascular load assessment at each titration step
100-tablet pack supports a complete titration cycle from 40 mcg through moderate working doses without resupply gaps
Batch-traceable HPLC potency data ensures the declared 40 mcg dose is instrument-verified, not inferred
Tablet format supports precise splitting to 20 mcg for cardiovascularly sensitive individuals beginning their first cycle
LAL endotoxin clearance on every batch eliminates pyrogen contamination risk associated with substandard oral tablet manufacturing
Kim Pharma's controlled-environment production standards extend particulate controls typically reserved for injectables to tablet compression operations
Single active ingredient formulation removes confounding cardiovascular variables introduced by multi-compound stacks
Clenbuterol is a synthetic sympathomimetic from the class of β2-adrenoceptor agonists, originally developed as a bronchodilator in veterinary and human medicine, and today studied primarily for its lipolytic and mildly anabolic properties.
Phase
dosage
Note
Cardiovascular Assessment Phase (Days 1–5)
40 mcg/day (1 tablet, or ½ tablet for sensitive individuals)
Establish pre-cycle resting HR and systolic BP baseline; record daily morning values before first tablet
First Escalation (Days 6–10)
80 mcg/day (2 tablets)
Escalate only if resting HR remains below 95 bpm and systolic BP below 135 mmHg at end of assessment phase
Second Escalation (Days 11–17)
120 mcg/day (3 tablets)
Pause escalation and hold at this dose if resting HR approaches 100 bpm or systolic nears 140 mmHg
•Monitor resting heart rate daily to stay below the 100 bpm threshold.
•Measure morning systolic blood pressure before every tablet during your cycle.
•Titrate upward in 40 mcg increments every 3–5 days to assess cardiovascular response.
•Avoid clenbuterol entirely if arrhythmia or uncontrolled hypertension is diagnosed.
•Request Kim Pharma's batch HPLC data to confirm exact tablet potency before starting.
Cardiovascular Load as the Defining Risk Variable of Clenbuterol Use
Clenbuterol is a long-acting sympathomimetic agent whose cardiovascular impact — quantified primarily through resting heart rate elevation and systolic blood pressure increase — represents the most clinically relevant safety boundary practitioners must manage during any structured fat-loss cycle. Unlike thermogenic stimulation or receptor sensitivity, both of which plateau predictably, cardiovascular strain scales with dose and individual sensitivity in ways that require active monitoring rather than passive protocol adherence. Kim Pharma's 40 mcg tablet format enables fine-grained dose titration precisely because cardiovascular response is the rate-limiting factor in most user protocols.
Heart Rate Elevations: Expected Ranges and Monitoring Thresholds
Heart rate increases from clenbuterol are dose-dependent and typically begin within one to two hours of oral ingestion. Published human pharmacodynamic data indicate resting heart rate elevations of 10–20 beats per minute (bpm) at doses in the 40–80 mcg range, with values at 120–160 mcg daily reaching increases of 25–40 bpm above individual baseline in sensitive users — a range documented in clinical overdose and performance-use case reports. Compared to ephedrine, which produces shorter-duration tachycardia peaking within 2–3 hours, clenbuterol's extended plasma half-life means heart rate elevation can persist for 16–24 hours, creating a sustained cardiac workload rather than a transient spike. A wearable heart rate monitor calibrated to the user's pre-cycle resting rate serves as a practical daily reference point; practitioners commonly define 100 bpm as an upper resting-rate threshold at which dose escalation should pause.
Systolic Blood Pressure, Cardiac Output, and High-Risk Populations
Clenbuterol drives systolic blood pressure upward through peripheral vasoconstriction and increased cardiac output; documented systolic increases of 10–25 mmHg have been recorded in human subjects at moderate recreational doses via standard sphygmomanometric measurement. Diastolic pressure effects are less consistent but can include a modest rise in high-dose scenarios. Clenbuterol elevates cardiac output by increasing both heart rate and myocardial contractility — a dual mechanism that places disproportionate stress on individuals with pre-existing hypertension, structural cardiac abnormalities, or reduced cardiac reserve. Individuals with a confirmed history of arrhythmia, hypertrophic cardiomyopathy, or uncontrolled hypertension carry substantially higher risk of adverse cardiovascular events and represent the primary contraindicated population. Morning resting blood pressure, measured consistently with a validated digital cuff before the first daily tablet, provides the most actionable monitoring signal during an active cycle.
Dose Titration as Cardiovascular Risk Mitigation
A structured ascending titration protocol — beginning at 40 mcg daily and increasing by 40 mcg per three-to-five day increment — allows cardiovascular adaptation assessment at each dose tier before further escalation. Kim Pharma's uniform 40 mcg tablet supports this structure directly: each tablet represents one defined titration increment. Any resting heart rate persistently exceeding 100 bpm or systolic blood pressure reading above 140 mmHg should prompt dose reduction rather than continuation, as sustained sympathomimetic overstimulation carries risks of cardiac remodelling with prolonged exposure documented in animal cardiomyocyte studies.
Usage
Measure and record your resting heart rate and morning systolic blood pressure for at least three consecutive days before taking the first tablet — this establishes the individual baseline against which all on-cycle cardiovascular data will be compared.
Take the daily dose in the morning with water to front-load the cardiovascular stimulation effect during waking hours, reducing nocturnal adrenergic exposure.
Use a validated digital wrist or arm cuff to check resting blood pressure and heart rate each morning before ingesting the day's tablet — log values in a cycle journal to identify trends early.
Increase dose by one tablet (40 mcg) only after completing at least four to five days at the current dose with resting HR consistently below 100 bpm and systolic BP consistently below 140 mmHg.
If resting heart rate exceeds 100 bpm or systolic pressure exceeds 140 mmHg on two or more consecutive morning readings, step back to the previous dose tier immediately rather than waiting for symptoms to resolve spontaneously.
During the final days of the cycle, reduce dose by 40 mcg every two days rather than stopping abruptly; monitor that resting heart rate returns toward pre-cycle baseline as a cardiovascular clearance signal before considering any future cycle.
Warnings
contraindications: Clenbuterol is contraindicated in individuals with arrhythmia, hypertrophic cardiomyopathy, uncontrolled hypertension, ischaemic heart disease, or known hypersensitivity to sympathomimetic agents. Individuals with thyroid disorders, diabetes, or compromised adrenal function should seek medical evaluation prior to use. Clenbuterol is not approved for human therapeutic use in the United States and carries regulatory restrictions in multiple jurisdictions.
side_effects: The most commonly reported cardiovascular side effects include sustained tachycardia, palpitations, and systolic hypertension. Non-cardiovascular effects include skeletal muscle tremor, diaphoresis, headache, and anxiety. Higher doses increase the probability and severity of all cardiovascular effects in a dose-dependent pattern. Prolonged high-dose exposure has been associated with cardiac hypertrophy in animal models.
monitoring: Daily morning resting heart rate and systolic blood pressure measurement with a validated cuff is the minimum monitoring standard during active clenbuterol use. A resting ECG before cycle initiation is advisable for any user with cardiovascular risk factors. Individuals over 35 or those with a family history of cardiac disease should consider a cardiology consultation before beginning any sympathomimetic protocol.
pct: Clenbuterol does not suppress the hypothalamic-pituitary-gonadal axis and does not require a traditional hormone-based post-cycle therapy. When used alongside anabolic steroids, standard PCT protocols applicable to those compounds apply independently. Cardiovascular parameters — particularly resting heart rate and blood pressure — should be tracked through the post-cycle period to confirm return to pre-cycle baseline values.
Frequently asked questions
How many beats per minute does clenbuterol typically raise resting heart rate at a 40–80 mcg daily dose?
At 40–80 mcg daily, resting heart rate typically rises by 10–20 bpm above individual baseline, based on published human pharmacodynamic data. Sensitive individuals may experience higher elevations. Practitioners commonly use 100 bpm as a practical ceiling for resting heart rate; any reading consistently above this threshold signals the need to reduce dose or pause the cycle rather than escalate further.
What systolic blood pressure reading should prompt a clenbuterol dose reduction?
A consistent morning systolic reading above 140 mmHg measured with a validated digital cuff is the standard threshold at which dose reduction is warranted. Clenbuterol raises systolic pressure by 10–25 mmHg in moderate recreational use ranges via increased cardiac output and peripheral vasoconstriction. Daily pre-dose measurement at the same time each morning provides the most reliable trend data for informed dose management.
Who should avoid clenbuterol due to cardiovascular risk?
Individuals with confirmed arrhythmia, hypertrophic cardiomyopathy, uncontrolled hypertension, or known structural cardiac abnormalities should not use clenbuterol. These conditions substantially elevate the risk of serious adverse cardiovascular events when a long-acting sympathomimetic agent increases heart rate and cardiac output simultaneously. A cardiologist evaluation and resting ECG are advisable before any clenbuterol-containing protocol for individuals with borderline cardiovascular markers.
Can Kim Pharma Clenbuterol 40mcg tablets be split for a lower starting dose?
Yes — Kim Pharma's 40 mcg tablets can be split to achieve a 20 mcg starting dose for individuals with heightened cardiovascular sensitivity or those new to sympathomimetic compounds. A 20 mcg starting point allows heart rate and blood pressure response to be assessed before escalating to a full 40 mcg unit, which is the minimum recommended starting dose in standard titration protocols.
How are Kim Pharma Clenbuterol tablets packaged, and does the format support accurate dosing across a full cycle?
Kim Pharma Clenbuterol is supplied in a 100-tablet format, providing a complete supply for a standard 8–10 week titration protocol at moderate dose ranges. The tablet format allows straightforward daily counting and dose-tracking, supporting the incremental 40 mcg step-up structure used in cardiovascular-load-aware protocols. Pack documentation — including HPLC potency data — is available on request, linking each pack to its specific production batch. (2) angle_used
Manufacturer
Kim Pharma's formulation development philosophy for its oral tablet range prioritises one principle that distinguishes it from volume-focused generic manufacturers: every process variable that could affect dose consistency in a low-concentration tablet — blend uniformity, granulation moisture content, compression force calibration — is treated as a critical quality attribute subject to in-process control rather than end-product testing alone. For Clenbuterol at 40 mcg per tablet, this approach is particularly consequential: a 10 % deviation at this dose level represents 4 mcg, a margin large enough to shift a user's cardiovascular response meaningfully. Kim Pharma addresses this by validating blending time and API dispersion at each batch scale rather than extrapolating from reference batches. Finished tablets undergo HPLC potency confirmation and LAL endotoxin testing before batch release, with documentation accessible to end users on request — providing a verified chain of custody from production through to the practitioner's hand.
Product details
Brand
Kim Pharma
Active ingredient
clenbuterol hydrochloride
Also known as
Clenbuterol, Clen, Spiropent, Kim Pharma Clenbuterol
Strength
40 mcg
Form
Tabletten
Pack size
100 pieces
Item number
WEIGHT-CLEN-KIM-017
Reviews
4.8/5
★★★★★★★★★★
14 reviews
5★11
4★3
3★0
2★0
1★0
★★★★★★★★★★Rating: 5 out of 5 starskevlarVerified purchase
Legit and fast acting
noticed the thermogenic effect within the first day at just 40mcg. By day 3 I was up to 80mcg and the shakes and sweats were exactly what you expect from real clen. lost 5.5kg over 8 weeks on a modest deficit. Sleep was a bit rough first week but settled down. Kim Pharma dosed these bang on, no underdosing issues like I had with a different brand last year.
★★★★★★★★★★Rating: 5 out of 5 starsSean52Verified purchase
Sweating through my shirt
Running 80mcg ed from week 2, dropped from 96kg to 89kg over 6 wks keeping cals the same. Hands shake a bit in the morning but that's just clen doing its job. appetite went way down which helped. Tabs are clean, no filler taste, came packaged well and arrived in 8 days. Solid product from Swiss Pharma, will reorder for my next cut.
★★★★★★★★★★Rating: 5 out of 5 starsdeadlift47Verified purchase
Best clen I've used
i've run clen from about four different sources over the years and this batch from Pharma Group hits harder and cleaner than most. started at 40mcg day 1, hit 120mcg by end of week 2. Sweating through everything, resting heart rate up about 15bpm, and the scale moved consistently - 7kg down over 8 wks while keeping protein at 220g a day. No chest tightness or weird sides. Shipping was discreet and fast, 9 days to the UK.
★★★★★★★★★★Rating: 5 out of 5 starsstorm35Verified purchase
Hilma quality is top tier
Used a few different clen sources over the years and Hilma is consistently the cleanest feeling. Dosed from 40mcg up to 100mcg across 2 weeks on prootcol. Sweats, elevated temp, appetite suppression all present and correct. Lipids on my bloods unchanged which I was buzzing about. Delivery was quick and discreet, 7 days to the US...
★★★★★★★★★★Rating: 5 out of 5 starsNickVerified purchase
Para Pharma never disappoints
Already trust Para Pharma from using their other products and this clen is no different. Ran 2 weeks on 2 weeks off protocol, maxed at 100mcg. Lost 4.2kg of fat while maintaining strength in the gym, bench actually went up 5kg during the cut which surprised me. Appetite suppression is strong, be ready for that. Arrived well packaged in 10 days. Reordering for sure 💪
★★★★★★★★★★Rating: 5 out of 5 starsstorm35Verified purchase
balkan never disappoints
Ran these at 40mcg to start, up to 120mcg by week 2. noticeable thermogenic effect within an hour of first dose, temperature up slightly, mild jitters. lost 6.5lbs over a 3 week run combined with cardio and a calorie deficit. Packaging from Balkan is always reassuring, holograms intact...
★★★★★★★★★★Rating: 5 out of 5 starskevlarVerified purchase
Proper clen, no bs
Does exactly what clen should do. Cramping was manageable with extra potassium and taurine. Ran 80mcg for 6 weeks alongside my cut, dropped from 104kg to 96.5kg. Cardio endurance actually went up too which was a bonus. Tabs split clean at 20mcg if you need to start low. Rossiaz brand is going on my reorder list.
★★★★★★★★★★Rating: 5 out of 5 starsdeadlift47
Dropped two belt notches
Wasn't expecting much tbh, been burned by weak clen before. This stuff hit at 40mcg heart rate up, temp up, appetite basically gone by lunchtime. Ran it 2 weeks on 2 weeks off for 10 weeks total. Went from 18% body fat down to around 13% by the end. Packaging was discreet, arrived in under two weeks. Chuffed with this one.
★★★★★★★★★★Rating: 4 out of 5 starskevlarVerified purchase
Good but pricey
Effective stuff, no doubt. Started at 40mcg and worked up to 120mcg over two weeks. Body temp definitely up, sweating loads at the gym. Only gripe is the price per tab compared to some other brands here. Results are real though lost about 4kg of fat in 5 weeks while holding onto most of my muscle. Would buy again if it goes on offer.
★★★★★★★★★★Rating: 5 out of 5 starsSean52Verified purchase
Clean and effective 👌
hilma tabs are always dosed accurately in my experience. Running 80mcg split AM and midday, no sleep issues if you cut it off by 2pm. Down 4lbs in 2.5 wks, holding muscle well with protein high. Will be restocking these without question
★★★★★★★★★★Rating: 5 out of 5 starsNickVerified purchase
solid thermogenic effect
could tell it was dosed properly from day one. Hands shaking slightly, body temp noticeably higher, sweating during workouts was on another level. Ran 80mcg ed for 5 wks, dropped from 88kg to 83kg. Cardio was tough with the elevated heart rate but pushed through. Would recommend Pharma Group if you want something that actually works.
★★★★★★★★★★Rating: 5 out of 5 starsJackVerified purchase
Real deal, no fakes here
Picked Para Pharma after reading good things and wasn't let down. 80mcg per day, felt it working within the first 24 hours elevated temp, mild tremors, sweating at rest, six week run, dropped from 93kg to 86kg. sleep was a bit disrupted weeks 1 and 2 so I moved my dose to morning only and that fixed it. Quality product, discreet shipping, happy with everything.
★★★★★★★★★★Rating: 4 out of 5 starsSean52Verified purchase
good tabs but hard to split
product itself is legit, effects kick in fast at 40mcg and I went up to 80mcg comfortably. my only gripe is the tabs are a bit crumbly when you try to halve them for titrating up carefully. lost a bit of powder a couple of times. But the fat loss effect is real, down 5lbs in 3 weeks. Would still buy again.
★★★★★★★★★★Rating: 4 out of 5 starsdeadlift47Verified purchase
works well, tabs a pain to split
Product is real for sure - temperature up within hours of first dose, appetite suppressed all day. My only issue is the tabs are quite hard and crumbled a bit when I tried to cut them in half for my ramp-up phase. Once I just swallowed 40mcg whole it was fine. Lost around 3kg in 4 weeks on top of what diet alone was doing. Good stuff overall.
Write a review
Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.
Clenbuterol 40mcg by Balkan Pharmaceuticals is a selective β2-adrenoceptor agonist in tablet form, whose binding to β2 receptors on adipocytes and bronchial smooth muscle triggers a cascade of intracellular cAMP elevation, driving enhanced lipolysis and basal metabolic rate — the biochemical core of its thermogenic action. Each 100-tablet unit delivers a precisely compressed 40 mcg dose, making incremental titration straightforward for users managing receptor sensitivity across a cycle. Quality assurance at the Chișinău facility is structured around a documented release sequence: post-compression HPLC quantification, in-process weight uniformity checks, and LAL endotoxin testing — all completed before batch release.
Pro-Clenbuterol by Beligas Pharmaceuticals is a 40 mcg Clenbuterol hydrochloride oral tablet formulated specifically for measurable thermogenic output — quantified as an elevation in resting body temperature and a documented increase in basal metabolic energy expenditure. Each of the 50 tablets in the pack delivers a precise dose calibrated to support the body's heat-production pathway, making energy expenditure the defining pharmacological lens through which this compound operates. Quality assurance is built into every production lot: HPLC chromatographic verification confirms the 40 mcg declared concentration against pharmacopoeial reference standards before a single blister strip leaves the facility.
ClenTrex by Concentrex Labs provides Clenbuterol Hydrochloride at 20 mcg per tablet — a sympathomimetic amine whose pharmacological value depends entirely on respecting the beta-2 receptor desensitisation window that uninterrupted use accelerates. The 100-tablet blister pack is counted to cover one complete active phase, letting users align intake precisely with a structured on/off protocol without mid-pack arithmetic. HPLC potency verification at the finished-tablet stage and LAL-tested excipient inputs are confirmed per released lot; the entire production chain runs inside a GMP-certified facility audited by an independent third party.
Elbrus Pharmaceuticals Clenbuterol delivers 50 mcg of pharmaceutical-grade clenbuterol hydrochloride per tablet across 60 tablets, engineered for athletes seeking to extend thermogenic effectiveness through ketotifen-assisted beta-2 receptor resensitization rather than conventional cycling breaks. By pairing this compound with ketotifen — an antihistamine documented to counteract agonist-induced beta-2 receptor desensitization — users can sustain continuous fatburner activity without the mandatory off-weeks that standard protocols demand. Each batch passes HPLC-verified content uniformity and LAL endotoxin screening; GMP-certified manufacturing conditions govern every compression and packaging stage.
Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.
Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.
EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.
Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.
Lab Tested
